Does the use of the checkpoint inhibitor nivolumab affect the outcomes of transplant?
Carmelo Carlo Stella
Overview of novel restore and target treatment approach to classical Hodgkin lymphoma
Evolving CLL treatments: creating choices and igniting discussions
Deborah Henderson et al.
Doublet vs triplet combination therapy for multiple myeloma
iwNHL 2017: The future of lymphoma research and treatment
Catherine Bollard et al.